Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether a digital support tool can help people with First episode psychosis, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is testing a medication approach for people with severe mental illness. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at how a digital support tool works for people with Psychosis or Mental and Behavioural Disorders in routine care. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether In both arms treatment as usual will be provided for the complaints that made the person seek help can help people with Psychosis, Mental and Behavioural Disorders, or Mental disorder. Participants take part in In both arms treatment as usual will be provided for the complaints that made the person seek help and complete follow-up assessments.
This study is looking at a support or therapy approach for people with Psychosis or Mental and Behavioural Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether 1 can help people with Mental and Behavioural Disorders: Psychosis, Mental and Behavioural Disorders, or Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a mental health workshop can help people with Psychiatric, mental disorders/illness, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in a mental health workshop and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with First episode psychosis, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at care and outcomes for people with Mental and Behavioural Disorders: Psychosis, Mental and Behavioural Disorders, or Psychosis. Taking part may give some people access to Two assessment scales, but direct benefit is not guaranteed.
This study is looking at whether questionnaires and follow-up can help people with Psychosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Mental and Behavioural Disorders: Psychosis, Mental and Behavioural Disorders, or Psychosis. Direct benefit is not guaranteed, but the study may help researchers improve future care.
This study is looking at whether cognitive behavioural therapy can help people with Mental and Behavioural Disorders: Psychosis or Mental and Behavioural Disorders. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Mental and Behavioural Disorders: Psychosis, Mental and Behavioural Disorders, or Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether cognitive behavioural therapy can help people with Psychosis or Mental and Behavioural Disorders. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
This observational study is following people with in nursing homes with moderate and severe psychotic symptoms or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether Intervention arm: Prucalopride (tablets, over-encapsulated in a vegetarian shell and filled with Lactose Monohydrate Ph can help people with community population with psychotic-like experiences in the last 12 months or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether psychoeducation can help people with psychosis or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether PAROXETINE compared with SERTRALINE HYDROCHLORIDE can help people with Major Depression, single or recurrent, without psychotic features - bipolarity, currently depressed, without psychotic features or Elderly. Participants receive one of the study medicines, such as PAROXETINE or SERTRALINE HYDROCHLORIDE, and complete study visits and assessments.
This study is comparing Samidorphan L-Malate with OLANZAPINE for people with Schizophrenia, schizophreniform disorder or Bipolarity type I. Participants receive Samidorphan L-Malate or OLANZAPINE and complete study visits and assessments.
This study is looking at whether Quetiapin can help people with The planned open and monocentric trial investigates quetiapine as a monotherapy for with unipolar depression and psychotic features. The aim of this pilot study is to investigate the antid.
This study is comparing sertraline hydrochloride with placebo for people with with First Episode Psychosis. Participants receive sertraline hydrochloride or placebo and complete study visits and assessments.
This study is looking at whether Metopiron can help people with unipolar depressive episode without psychotic features according to DSM-IV-TR. Participants receive the study medicine Metopiron and complete study visits and assessments.
This study is comparing Clonidine HCL with placebo for people with Schizophrenia, schizophreniform disorder, schizoaffective disorder. Participants receive Clonidine HCL or placebo and complete study visits and assessments.
This study is comparing Raloxifeno with placebo for people with Trastorno esquizofrénico or Elderly. Participants receive Raloxifeno or placebo and complete study visits and assessments.
This study is looking at whether Quetiapine fumarate can help people with A prospective 8 weeks acute phase study investigating efficacy, safety and tolerability of Quetiapine fumarate in 60 drug-naïve first-episode psychosis aged 18 to 35 years. Participants receive the study medicine Quetiapine fumarate and complete study visits and assessments.